These emerging therapies, including Semaglutide , a similar compound, and another option, represent a major advancement in addressing type 2 the condition and promoting weight management. They work by mimicking the body’s natural peptide GLP-1 , enabling to control blood levels and reduce hunger . The drug has slightly unique characteristics and